EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Use of Xpert MTB/RIF Ultra Testing for Early Diagnosis of Tuberculosis: A Retrospective Study from a Single-Center Database

Cristian Sava iD, Mihaela Sava, Ana-Maria Drăgan, Alin Iuhas iD, Larisa Niulaș iD, Cristian Phillip Marinău, Andreea Bianca Balmoș

Genes · 2023

DOI: 10.3390/genes14061231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Cristian Sava und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary, Mycobacterium tuberculosis, Antibiotics, Antitubercular, Tuberculosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB) is a multisystemic contagious disease produced by Mycobacterium tuberculosis complex bacteria (MTBC), with a prevalence of 65:100,000 inhabitants in Romania (six times higher than the European average). The diagnosis usually relies on the detection of MTBC in culture. Although this is a sensitive method of detection and remains the “gold standard”, the results are obtained after several weeks. Nucleic acid amplification tests (NAATs), being a quick and sensitive method, represent progress in the diagnosis of TB. The aim of this study is to assess the assumption that NAAT using Xpert MTB/RIF is an efficient method of TB diagnosis and has the capacity to reduce false-positive results. Pathological samples from 862 patients with TB suspicion were tested using microscopic examination, molecular testing and bacterial culture. The results show that the Xpert MTB/RIF Ultra test has a sensitivity of 95% and a specificity of 96.4% compared with 54.8% sensitivity and 99.5% specificity for Ziehl–Neelsen stain microscopy, and an average of 30 days gained in the diagnosis of TB compared with bacterial culture. The implementation of molecular testing in TB laboratories leads to an important increase in early diagnostics of the disease and the prompter isolation and treatment of infected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, PulmonaryMycobacterium tuberculosisAntibiotics, AntitubercularTuberculosisHumansRetrospective StudiesRifampinSensitivity and SpecificityEarly Diagnosis

Stichwörter der Autor:innen

Lowenstein–Jensen medium cultureXpert MTB/RIF UltraZiehl–Neelsen stainingmolecular testingtuberculosis

Substanzen

RifampinAntibiotics, Antitubercular

Autor:innen und Institutionen

  • Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.
  • Clinical Emergency Bihor County Hospital, 410167 Oradea, Romania.

ORCID-Profile: Cristian Sava, Alin Iuhas, Larisa Niulaș

Zitieren

APA

Sava, C., Sava, M., Drăgan, A. M., Iuhas, A., Niulaș, L., Marinău, C. P., & Balmoș, A. B. (2023). The Use of Xpert MTB/RIF Ultra Testing for Early Diagnosis of Tuberculosis: A Retrospective Study from a Single-Center Database. Genes. https://doi.org/10.3390/genes14061231

Vancouver

Sava C, Sava M, Drăgan AM, Iuhas A, Niulaș L, Marinău CP, et al. The Use of Xpert MTB/RIF Ultra Testing for Early Diagnosis of Tuberculosis: A Retrospective Study from a Single-Center Database. Genes. 2023. doi:10.3390/genes14061231

BibTeX
@article{Sava2023,
  author = {Sava, Cristian and Sava, Mihaela and Drăgan, Ana-Maria and Iuhas, Alin and Niulaș, Larisa and Marinău, Cristian Phillip and Balmoș, Andreea Bianca},
  title = {The Use of Xpert MTB/RIF Ultra Testing for Early Diagnosis of Tuberculosis: A Retrospective Study from a Single-Center Database},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14061231}
}
Kostenlos starten →